| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |